Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deborah Ashby

Showing results (71-80 of 128) with videos related to

Pageof 13
Sort By:
American Journal of Public Health|September 21, 2023
Design and Implementation of a National Program to Monitor the Prevalence of SARS-CoV-2 IgG Antibodies in England Using Self-Testing: The REACT-2 StudyHelen Ward, Christina Atchison, Matthew Whitaker, et al.
Open Forum Infectious Diseases|November 19, 2021
Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key WorkersBethan Davies, Marzieh Araghi, Maya Moshe, et al.
Trials|June 17, 2017
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trialPeter Saunders, Vicky Tsipouri, Gregory J Keir, et al.
Plos Biology|May 25, 2023
Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in EnglandOliver Eales, David Haw, Haowei Wang, et al.
Diabetes Care|June 6, 2014
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trialKonstantinos K Tsilidis, Despoina Capothanassi, Naomi E Allen, et al.
BMC Musculoskeletal Disorders|January 30, 2007
Managing Injuries of the Neck Trial (MINT): design of a randomised controlled trial of treatments for whiplash associated disordersSarah E Lamb, Simon Gates, Martin R Underwood, et al.
Epidemics|July 3, 2022
Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction numberOliver Eales, Kylie E C Ainslie, Caroline E Walters, et al.
Lancet (London, England)|December 25, 2012
Emergency department treatments and physiotherapy for acute whiplash: a pragmatic, two-step, randomised controlled trialSarah E Lamb, Simon Gates, Mark A Williams, et al.
Nature Communications|February 11, 2021
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemicHelen Ward, Christina Atchison, Matthew Whitaker, et al.
Plos Computational Biology|November 23, 2022
Trends in SARS-CoV-2 infection prevalence during England's roadmap out of lockdown, January to July 2021Oliver Eales, Haowei Wang, David Haw, et al.
Pageof 13

Showing results (71-80 of 128) with videos related to

Sort By:
Pageof 13
American Journal of Public Health|September 21, 2023
Design and Implementation of a National Program to Monitor the Prevalence of SARS-CoV-2 IgG Antibodies in England Using Self-Testing: The REACT-2 StudyHelen Ward, Christina Atchison, Matthew Whitaker, et al.
Open Forum Infectious Diseases|November 19, 2021
Acceptability, Usability, and Performance of Lateral Flow Immunoassay Tests for Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: REACT-2 Study of Self-Testing in Nonhealthcare Key WorkersBethan Davies, Marzieh Araghi, Maya Moshe, et al.
Trials|June 17, 2017
Rituximab versus cyclophosphamide for the treatment of connective tissue disease-associated interstitial lung disease (RECITAL): study protocol for a randomised controlled trialPeter Saunders, Vicky Tsipouri, Gregory J Keir, et al.
Plos Biology|May 25, 2023
Dynamics of SARS-CoV-2 infection hospitalisation and infection fatality ratios over 23 months in EnglandOliver Eales, David Haw, Haowei Wang, et al.
Diabetes Care|June 6, 2014
Metformin does not affect cancer risk: a cohort study in the U.K. Clinical Practice Research Datalink analyzed like an intention-to-treat trialKonstantinos K Tsilidis, Despoina Capothanassi, Naomi E Allen, et al.
BMC Musculoskeletal Disorders|January 30, 2007
Managing Injuries of the Neck Trial (MINT): design of a randomised controlled trial of treatments for whiplash associated disordersSarah E Lamb, Simon Gates, Martin R Underwood, et al.
Epidemics|July 3, 2022
Appropriately smoothing prevalence data to inform estimates of growth rate and reproduction numberOliver Eales, Kylie E C Ainslie, Caroline E Walters, et al.
Lancet (London, England)|December 25, 2012
Emergency department treatments and physiotherapy for acute whiplash: a pragmatic, two-step, randomised controlled trialSarah E Lamb, Simon Gates, Mark A Williams, et al.
Nature Communications|February 11, 2021
SARS-CoV-2 antibody prevalence in England following the first peak of the pandemicHelen Ward, Christina Atchison, Matthew Whitaker, et al.
Plos Computational Biology|November 23, 2022
Trends in SARS-CoV-2 infection prevalence during England's roadmap out of lockdown, January to July 2021Oliver Eales, Haowei Wang, David Haw, et al.
Pageof 13